Summary: The Centers for Medicare & Medicaid Services modified its Prothrombin Time (PT) coverage policy, effective May 15, 2026. Here's what billing teams need to know before that date.

Prothrombin Time testing is one of the most commonly billed lab services in Medicare. CMS prothrombin time coverage policy changes can ripple through high-volume billing workflows fast — especially for labs, anticoagulation clinics, and practices managing patients on warfarin. The policy document does not list specific CPT, HCPCS, or ICD-10 codes in the available data. We'll cover what's known, what to watch for, and how to protect your claims.


Quick-Reference Table

Field Detail
Payer CMS
Policy Prothrombin Time (PT)
Policy Code N/A
Change Type Modified
Effective Date May 15, 2026
Impact Level Medium-High
Specialties Affected Clinical Laboratory, Internal Medicine, Cardiology, Hematology, Anticoagulation Management, Primary Care
Key Action Audit your PT billing workflows and medical necessity documentation before May 15, 2026

CMS Prothrombin Time Coverage Criteria and Medical Necessity Requirements 2026

The Centers for Medicare & Medicaid Services governs PT test coverage under its national lab testing framework. For billing teams, the core question is always the same: does the claim tie back to a documented, medically necessary reason to order the test?

CMS evaluates medical necessity for PT testing based on the clinical context. Common covered indications include monitoring patients on anticoagulation therapy — primarily warfarin — and evaluating bleeding disorders, liver disease, or vitamin K deficiency. The ordering provider must document the clinical indication in the medical record, and that documentation has to match the diagnosis code on the claim.

The CMS prothrombin time coverage policy has historically been administered at the local level through Medicare Administrative Contractors. That means your MAC — whether Novitas, NGS, CGS, WPS, or another — may have a local coverage determination (LCD) that adds criteria beyond the national baseline. If you bill in multiple regions, you may be working against different documentation standards for the same test.

Prior authorization is not typically required for PT testing under Medicare fee-for-service. But that doesn't mean coverage is automatic. CMS and its MACs can and do deny claims for PT tests that lack sufficient medical necessity documentation, even when no prior authorization requirement exists. A clean claim still needs a defensible diagnosis code and a documented clinical reason.

One thing to watch: CMS has tightened how it handles routine or standing lab orders in recent years. If your practice uses a recurring order for PT monitoring, confirm that the order is reviewed and re-authorized by the provider on a schedule that satisfies your MAC's documentation standards. Stale standing orders are a claim denial risk.


This policy is now in effect (since 2026-05-15). Verify your claims match the updated criteria above.

CMS Prothrombin Time Billing Guidelines and Action Items 2026

The policy data available for this change does not include a line-by-line summary of what CMS modified. That's worth saying plainly — it means your billing team needs to go directly to the source and confirm what changed before the effective date of May 15, 2026.

Here are the action items based on what we know about CMS PT billing and the nature of this policy modification:

#Action Item
1

Pull your MAC's current LCD for PT testing now. Go to the CMS LCD & NCD search tool and look up your MAC's local coverage determination for prothrombin time. Compare it against what your billing team is currently documenting. If there's a gap, fix it before May 15, 2026.

2

Audit your medical necessity documentation for standing PT orders. Run a report of all open or recurring PT orders in your system. For each one, confirm the provider has a current, documented clinical reason — not just a historical note. This is the most common source of claim denial for lab tests.

3

Check your charge capture for PT. The policy data does not list specific CPT or HCPCS codes. That means you need to verify which codes your lab or practice bills for prothrombin time testing and confirm those codes align with what CMS covers under this modified policy. Don't assume last year's setup is still correct.

+ 3 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

CMS Prothrombin Time Exclusions and Non-Covered Indications

CMS does not cover PT testing when there is no documented medical necessity for the test. That sounds obvious, but it's the real source of most denials in practice.

Specifically, watch for these scenarios that routinely result in non-coverage:

Screening without clinical indication. PT is not a covered screening test for asymptomatic patients with no documented risk factor or active condition that requires monitoring. If the diagnosis code doesn't support a clinical reason for the test, the claim will be denied.

Duplicate testing. CMS and its MACs flag PT tests billed more frequently than the clinical situation supports. If a patient is stable on warfarin and your documentation doesn't reflect a reason for more frequent monitoring, expect scrutiny on the frequency of billing.

Missing or mismatched diagnosis codes. The diagnosis code on the claim must match the documented clinical indication. A PT test ordered for anticoagulation monitoring needs a diagnosis code that reflects that. A generic or vague code that doesn't connect to a real monitoring or diagnostic purpose is a denial waiting to happen.


Coverage Indications at a Glance

The policy data for this CMS modification does not include a detailed indication-by-indication breakdown. The table below reflects standard CMS PT testing coverage positions based on established billing guidelines. Confirm these against your MAC's LCD before the effective date.

Indication Status Notes
Monitoring patients on warfarin anticoagulation therapy Covered Must document INR target range and clinical reason for monitoring frequency
Evaluation of bleeding disorder Covered Requires documented clinical presentation supporting the diagnostic workup
Evaluation of liver disease or hepatic function Covered PT used as part of a liver function panel — document the underlying condition
+ 4 more indications

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Sample Version Diff Line-by-line changes
Previous VersionCurrent Version
Coverage is considered experimental and investigational for all indicationsCoverage is considered medically necessary when specific criteria are met
Prior authorization is not requiredPrior authorization is required for initial treatment
Documentation must include clinical historyDocumentation must include clinical history
+ 1 more indications

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

CPT, HCPCS, and ICD-10 Codes for Prothrombin Time Under This Policy

The available policy data for this CMS modification does not list specific CPT, HCPCS, or ICD-10 codes. Do not assume which codes are affected based on the policy title alone.

Here's what to do instead:

Verify Codes With Your MAC

The CPT codes typically associated with prothrombin time testing are well-established in clinical laboratory billing. Your MAC's LCD will specify exactly which codes are covered, which require additional documentation, and whether any codes have been added or removed under this modification. Pull that LCD now.

Check CMS's Fee Schedule

Reimbursement rates for lab tests are set under the Clinical Laboratory Fee Schedule (CLFS). If this policy modification changes the covered indications or billing guidelines for PT, it may also affect how claims are priced. Check the CLFS for the relevant codes once you've confirmed which codes apply.

Do Not Guess

Adding codes to your charge capture based on a policy title and general knowledge — without confirming against the actual policy document and your MAC's LCD — is how billing errors happen. Get the source document. The CMS policy is available at app.payerpolicy.org/p/cms/80-v1.


The Real Issue With This Policy Change

Here's the honest take: a CMS modification to a high-volume lab test policy with no detailed summary available in the policy data is a red flag for billing teams, not a routine update.

PT testing runs through anticoagulation clinics, primary care offices, labs, and hospital outpatient departments in enormous volume. Even a small change in medical necessity criteria or documentation requirements can generate significant claim denial exposure across your book of business.

The effective date of May 15, 2026 gives you a window. Use it. Don't wait for a denial trend to tell you something changed — find out what changed now and adjust your billing workflows before claims start dropping.


Get the Full Picture

Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.

🔍 Search by any code 🔔 Real-time alerts 📊 Line-by-line diffs ⏰ Deadline tracking
Get Full Access → $99/mo · 14-day money-back guarantee